---

Annals of Internal Medicine publishes new CDC recommendations on hepatitis C screening

August 17, 2012

Without other risk factors, all Americans born between 1945 and 1965 should have a one-time screening for the hepatitis C virus (HCV) according to new recommendations being published early online today in Annals of Internal Medicine, the flagship journal of the American College of Physicians. The Centers for Disease Control and Prevention (CDC) also recommends that all persons identified with HCV should receive a brief alcohol screening and intervention and be referred to appropriate care and treatment services for HCV and related conditions.

Up to 3.9 million people in the United States are infected with HCV, a virus that can cause inflammation and permanent liver damage. The infection is most prevalent among people born from 1945 through 1965, and approximately 50 to 75 percent of those with HCV are unaware that they are infected. This is a problem because HCV progresses slowly, and the risk of serious complications increases as time passes.

The recommendation developers sought to identify testing strategies that would increase the proportion of HCV-infected persons who know their status. In particular, whether a testing strategy based on year of birth would identify persons living with HCV infection who have not been identified by risk-based testing. They conducted a systematic review of evidence published between 1995 and February 2012 to assess the prevalence of HCV and clinical outcomes. They found that the proportion of people born between 1945 and 1965 with HCV antibody was higher than that of the general population. Among that cohort, the recommendation authors found strong evidence that achieving sustained virologic response (SVR) was associated with reduced risk for death and liver cancer.

The CDC recommends that persons identified with HCV have a brief alcohol screening and intervention, as alcohol use has been shown to accelerate the progression of liver disease. The recommendation authors considered evidence from a systematic review of 22 randomized, controlled trials published since 2010 to determine the effects of a brief alcohol intervention versus no intervention on reduction of alcohol use. The research showed that patients who had a brief alcohol reduction intervention reduced their weekly alcohol consumption by an average of 38.42 grams compared with those who had no intervention.

Previously, the CDC recommended antibody screening only of individuals with health or lifestyle indicators suggesting potential infection. These indicators include a history of injecting drugs, having a blood transfusion before 1992, or being a chronic hemodialysis patient. Low case identification may result from the difficulty of implementing risk-based screening given the limited time of primary care visits and unease in discussing behavioral risks.

American College of Physicians

Related Hepatitis C Current Events and Hepatitis C News Articles

New Loyola study on hepatitis C virus entry factor
Hepatitis C virus (HCV) infects more than 170 million people worldwide. Approximately 80 percent of infections lead to chronic illness including fibrosis, cirrhosis, cancer and also hepatic iron overload.

Vitamin D deficiency may help spread of hepatitis B throughout liver
Researchers from Germany have found that low levels of vitamin D are associated with high levels of hepatitis B virus (HBV) replication.

Mount Sinai discovers new liver cell for cellular therapy to aid in liver regeneration
Liver transplantation is the mainstay of treatment for patients with end-stage liver disease, the 12th leading cause of death in the United States, but new research from the Icahn School of Medicine at Mount Sinai, published in the online journal Cell Stem Cell today, suggests that it may one day become possible to regenerate a liver using cell therapy in patients with liver disease.

A step closer to artificial livers
Prometheus, the mythological figure who stole fire from the gods, was punished for this theft by being bound to a rock. Each day, an eagle swept down and fed on his liver, which then grew back to be eaten again the next day.

JPIDS: Releases consensus statement on research definitions for drug-resistant TB in children
The Journal of the Pediatric Infectious Diseases Society (JPIDS) today released its June issue, which includes a consensus statement of the global Sentinel Project on Pediatric Drug-Resistant Tuberculosis.

Pharmaceutical advances offer new options for health outcomes
Research presented at Digestive Disease Week® (DDW) explores pharmaceutical advances for treating irritable bowel syndrome with diarrhea (IBS-D) and hepatitis C.

Treatment for novel coronavirus shows promise in early lab tests
National Institutes of Health (NIH) scientists studying an emerging coronavirus have found that a combination of two licensed antiviral drugs, ribavirin and interferon-alpha 2b, can stop the virus from replicating in laboratory-grown cells.

Study finds interferon, one of the body's proteins, induces persistent viral infection
Scientists at The Scripps Research Institute (TSRI) have made a counterintuitive finding that may lead to new ways to clear persistent infection that is the hallmark of such diseases as AIDS, hepatitis B and hepatitis C.

UCLA study suggests potential therapy for HIV
UCLA scientists have shown that temporarily blocking a protein critical to immune response actually helps the body clear itself of chronic infection.

Take a kidney transplant now or wait for a better one? Hopkins researchers create 'decision' tool
Johns Hopkins scientists have created a free, Web-based tool to help patients decide whether it's best to accept an immediately available, but less-than-ideal deceased donor kidney for transplant, or wait for a healthier one in the future.

---

More Hepatitis C Current Events and Hepatitis C News Articles

---